REGENERON FARMASYUTIKALZ INK has a total of 14 patent applications. Its first patent ever was published in 2012. It filed its patents most often in Russian Federation. Its main competitors in its focus markets biotechnology, agriculture and pharmaceuticals are CRESCENDO BIOLOG LTD, OMT INC and CRYSTAL BIOSCIENCE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Russian Federation | 14 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Agriculture | |
#3 | Pharmaceuticals | |
#4 | Measurement | |
#5 | Organic fine chemistry | |
#6 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Animal care | |
#4 | Medical preparations | |
#5 | Analysing materials | |
#6 | Therapeutic chemical compounds | |
#7 | Sugars | |
#8 | Measuring microorganism processes | |
#9 | Microbiology | |
#10 | Chemical or physical laboratory devices |
# | Name | Total Patents |
---|---|---|
#1 | Makdonald Linn | 4 |
#2 | Murphy Andrew J | 4 |
#3 | Mcwhirter John | 3 |
#4 | Makvirter Dzhon | 3 |
#5 | Merfi Endryu Dzhej | 3 |
#6 | Stivens Shon | 3 |
#7 | Macdonald Lynn | 3 |
#8 | Voronina Vera | 2 |
#9 | Merfi Endryu Dzh | 2 |
#10 | Tu Naksin | 2 |
Publication | Filing date | Title |
---|---|---|
RU2745403C2 | Non-human animals having humanized lymphocyte-activation gene 3 | |
RU2644684C2 | Antibodies with built in the light circuit by hystidine and genetically modified excellent from human animals for their obtaining |